ACE2 and heart failure: Regarding heart failure treatment, BAC directly targets angiotensin-converting enzyme 2 (ACE2), thereby inhibiting the activation of the p38/extracellular signal-regulated kinase signaling–mediated mitochondrial reactive oxygen species (ROS) and nuclear factor (NF)-κB pathways.